Nav: Home

No cell is an island

June 25, 2019

LA JOLLA, CA - Sorting through individual immune cells is a handy way to see how the body responds to disease. For years, researchers around the world have used a technique called flow cytometry to separate different types of immune cells, such as T cells, B cells and monocytes. But occasionally they'd see two cells stuck together as a "doublet." Many regarded doublets as an artefact of the flow cytometry process, and it was common place to "dump" those conjoined cells before gathering data.

That was until scientists at the La Jolla Institute of Immunology (LJI) took a closer look at doublets and uncovered their link to disease. In a new study, published on June 25, 2019, in the journal eLife, the researchers report that higher levels of doublets can be found in people with severe cases of tuberculosis or dengue fever.

This finding shows that doublets are not simply technical artefacts of the flow cytometry process. Instead of ignoring these doublets, scientists could study them to predict disease progression and even vaccine effectiveness.

"It's an important lesson learned," says Bjoern Peters, Ph.D., a professor in the Vaccine Discovery Division at LJI and senior author of the new study. "By studying these cells and how they communicate, we might learn more about the immune system."

The presence of doublets also explains cases where an immune cell appears to show gene expression of two distinct types of immune cells. Peters and his team have studied thousands of these odd "double expressors" and shown that these are actually doublets. "You look closer, and really it's two cells," says Peters.

The team was inspired to investigate doublets when they ran into a puzzling group of cells in blood samples from patients with tuberculosis. Their flow cytometry experiments revealed immune cells in these patients the characteristics of both monocyte cells and T cells. The scientists saw the same strange cells in patients with dengue fever.

Julie Burel, Ph.D., postdoctoral research fellow at LJI, realized that high levels of these double expressors correlated with a higher risk of disease progression in the patients. Her follow-up experiments showed that these cells were in reality doublets made up of a monocyte and a T cell stuck together.

The researchers then started looking for these doublets in more samples. They found that while recently infected patients tend to have more doublets, doublets appear to be surprisingly common in everyone. "Every blood sample we've analyzed contains doublets," says Burel, who served as first author of the new study.

So why did it take so long to find them?

"Instrument sensitivity is a lot higher now, so we're able to see things no one could see 10 years ago," Peters says.

The presence of doublets makes complete sense if you consider the role of T cells in the body, Peters explains. "T cells are meant to monitor what's going on in other cells, and detect and even kill infected cells --so it makes sense to study T cells that are found in complexes with other cells," says Peters.

In tuberculosis and dengue fever, monocytes become reservoirs for disease, so T cells would be more likely to come in contact with monocytes and form doublets.

Peters says doublets are likely relevant in many other diseases. After all, infection prompts immune cells to communicate and interact more closely. That could mean they are more likely to form doublets. "The immune system is a very complicated, social network," says Burel. "Flow cytometry is meant to break cells apart, but actually, doublets matter."

As Peters likes to put it, "no cell is an island." The new research has inspired his lab to look beyond the single-cell analysis usually done with flow cytometry and instead gather more data on doublets.

One question is whether measuring doublets could allow researchers to detect disease before a patient even shows the symptoms. This could be critical for stopping fast-moving diseases such as dengue. Doublets could also indicate when a vaccine is sparking an effective immune response, which could help speed up vaccine research.

"Doublets could be a biomarker for any immune perturbation," Burel says.
Full citation:

Julie G. Burel, Mikhail Pomaznoy, Cecilia S. Lindestam Arlehamn, Daniela Weiskopf, Ricardo da Silva Antunes, Yunmin Jung, Mariana Babor, Veronique Schulten, Grégory Seumois, Jason A. Greenbaum, Sunil Premawansa, Gayani Premawansa, Ananda Wijewickrama, Dhammika Vidanagama, Bandu Gunasena, Rashmi Tippalagama, Aruna D. deSilva, Robert H. Gilman, Mayuko Saito, Randy Taplitz, Klaus Ley, Pandurangan Vijayanand, Alessandro Sette and Bjoern Peters. Circulating T cell-monocyte complexes are markers of immune perturbations. eLife. 2019

DOI: 10.7554/eLife.46045

About La Jolla Institute for Immunology

The La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading toward its goal: life without disease.

La Jolla Institute for Immunology

Related Tuberculosis Articles:

Tuberculosis: New insights into the pathogen
Researchers at the University of W├╝rzburg and the Spanish Cancer Research Centre have gained new insights into the pathogen that causes tuberculosis.
Unmasking the hidden burden of tuberculosis in Mozambique
The real burden of tuberculosis is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital.
HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.
Reducing the burden of tuberculosis treatment
A research team led by MIT has developed a device that can lodge in the stomach and deliver antibiotics to treat tuberculosis, which they hope will make it easier to cure more patients and reduce health care costs.
Tuberculosis: Commandeering a bacterial 'suicide' mechanism
The bacteria responsible for tuberculosis can be killed by a toxin they produce unless it is neutralized by an antidote protein.
A copper bullet for tuberculosis
Tuberculosis is a sneaky disease, and the number one cause of death from infectious disease worldwide.
How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.
How many people die from tuberculosis every year?
The estimates for global tuberculosis deaths by the World Health Organisation (WHO) and the Institute for Health Metrics and Evaluation (IHME) differ considerably for a dozen countries, according to a study led by ISGlobal.
Beyond killing tuberculosis
Historically, our view of host defense against infection was that we must eliminate pathogens to eradicate disease.
Tuberculosis drugs work better with vitamin C
Studies in mice and in tissue cultures suggest that giving vitamin C with tuberculosis drugs could reduce the unusually long time it takes these drugs to eradicate this pathogen.
More Tuberculosis News and Tuberculosis Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.